The analgesic effect of intrathecal dexmedetomidine or clonidine, with bupivacaine, in trauma patients undergoing lower limb surgery: A randomised, double-blind study

Anaesthesia and Intensive Care

Volumn 41, Issue 1, 2013, Pages 51-56

  Solanki, S L ^a,b   Bharti, N ^a   Batra, Y K ^a   Jain, A ^a   Kumar, P ^a   Nikhar, S A ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

Analgesia; Clonidine; Dexmedetomidine: Intrathecal; Trauma

Indexed keywords

BUPIVACAINE; CLONEON; CLONIDINE; DEXMEDETOMIDINE; DEXTOMID; DICLOFENAC; MORPHINE; UNCLASSIFIED DRUG; ANALGESIC AGENT; LOCAL ANESTHETIC AGENT;

ADD ON THERAPY; ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; HYPOTENSION; LEG; MAJOR CLINICAL STUDY; MALE; NERVE BLOCK; ORTHOPEDIC SURGERY; PAIN ASSESSMENT; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL; SPINAL ANESTHESIA; SURGICAL PATIENT; TREATMENT DURATION; ADOLESCENT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; INJURY; INTRASPINAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME;

ADOLESCENT; ADULT; AGED; ANALGESICS; ANALGESICS, NON-NARCOTIC; ANESTHETICS, LOCAL; BUPIVACAINE; CLONIDINE; DEXMEDETOMIDINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, SPINAL; LOWER EXTREMITY; MALE; MIDDLE AGED; NERVE BLOCK; PAIN, POSTOPERATIVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; WOUNDS AND INJURIES; YOUNG ADULT;

MLCS; MLOWN;

EID: 84874417866     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1304100110     Document Type: Article

References (21)

1. Viscusi ER, Martin G, Hartrick CT, Singla N, Manvelian G, EREM Study Group. Forty-eight hours of postoperative pain relief after total hip arthroplasty with a novel, extendedrelease epidural morphine formulation. Anesthesiology 2005; 102:1014-1022.
2. Horlocker TT. Regional anesthesia and analgesia in the orthopedic patient receiving thromboprophylaxis. Tech Reg Anesth Pain Manag 1999; 3:120-125.
3. Dobrydnjov I, Axelsson K, Samarutel J, Holmstrom B. Postoperative pain relief following intrathecal or oral clonidine. Acta Anaesthesiol Scand 2002; 46:806-814.
4. Strebel S, Gurzeler JA, Schneider MC, Aeschbach A, Kindler CH. Small-dose intrathecal clonidine and isobaric bupivacaine for orthopedic surgery: A dose-response study. Anesth Analg 2004; 99:1231-1238.
5. van Tuijl I, van Klei WA, van der Werff DB, Kalkman CJ. The effect of addition of intrathecal clonidine to hyperbaric bupivacaine on postoperative pain and morphine requirements after Caesarean section: A randomized controlled trial. Br J Anaesth 2006; 97:365-370.
6. N iemi L. Effects of intrathecal clonidine on duration of bupivacaine spinal anaesthesia, haemodynamics, and postoperative analgesia in patients undergoing knee arthroscopy. Acta Anaesthesiol Scand 1994; 38:724-728.
7. Chiari A, Lorber C, Eisenach JC, Wildling E, Krenn C, Zavrsky A et al. Analgesic and hemodynamic effects of intrathecal clonidine as the sole analgesic agent during first stage of labor. Anesthesiology 1999; 91:388-396.
8. K also EA, Pöyhiä R, Rosenberg PH. Spinal antinociception by dexmedetomidine, a highly selective alpha 2-adrenergic agonist. Pharmacol Toxicol 1991; 68:140-143.
9. Kanazi GE, Aouad MT, Jabbour-Khoury SI, Al Jazzar MD, Alameddine MM, Al-Yaman R et al. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand 2006; 50:222-227.
10. Smith MS, Schambra UB, Wilson KH, Page SO, Hulette C, Light AR et al. Alpha 2-Adrenergic receptors in human spinal cord: Specific localized expression of mRNA encoding alpha 2-adrenergic receptor subtypes at four distinct levels. Brain Res Mol Brain Res 1995; 34:109-117.
11. Lawhead RG, Blaxall HS, Bylund BD. Alpha-2A is the predominant alpha-2 adrenergic receptor subtype in human spinal cord. Anesthesiology 1992; 77:983-991.
12. Smith C, Birnbaum G, Carter JL, Greenstein J, Lublin FD. Tizanidine treatment of spasticity caused by multiple sclerosis: Results of a double-blind, placebo-controlled trial. US Tizanidine Study Group. Neurology 1994; 44:S34-42.
13. Al-Ghanem SM, Massad IM, Al-Mustafa MM, Al-Zaben KR, Qudaisat IY, qatawneh AM et al. Effect of adding dexmedetomidine versus fentanyl to intrathecal bupivacaine on spinal block characteristics in gynecological procedures: A double blind controlled study. Am Jr Appl Sci 2009; 6:882-887.
14. Gupta R, Verma R, Bogra J, Kohli M, Raman R, Kushwaha JK. A comparative study of intrathecal dexmedetomidine and fentanyl as adjuvants to Bupivacaine. J Anaesthesiol Clin Pharmacol 2011; 27:339-343.
15. Post C, Gordh T, Minor G, Archer T, Freedman J. Antinociceptive effects and spinal cord tissue concentrations after intrathecal injection of guanfacine or clonidine into rats. Anesth Analg 1987; 66:317-324.
16. Yaksh TL, Jage J, Takano Y. Pharmacokinetics and pharmacodynamics of medullar agents. The spinal actions of a-2 adrenergic agonists as analgesics. In: Atikenhead, AR, Benad, G, Brown, BR, et al. Baillière's Clinical Anaesthesiology, Vol. 7, No. 3. London: Baillière Tindall 1993; 597-614.
17. Maroof M, Khan SA, Jain D, Khan RM, Maroof SM. Evaluation of effect of dexmedetomidine in reducing shivering following epidural anesthesia. Anesthesiology 2004; 101:A495.
18. Fukushima K, Nishimi Y, Mori K, Takeda J. Effect of epidurally administered dexmedetomidine on sympathetic activity and postoperative pain in man. Anesth Analg 1996; 82:S121.
19. Eisenach JC, Shafer SL, Bucklin BA, Jackson C, Kallio A. Pharmacokinetics and pharmacodynamics of intraspinal dexmedetomidine in sheep. Anesthesiology 1994; 80:1349-1359.
20. Lo WC, Harris J, Clarke RW. Endogenous opioids support the spinal inhibitory action of an alpha 2-adrenoceptor agonist in the decerebrated, spinalised rabbit. Neurosci Lett 2003; 340:95- 98.
21. Horvath G, Joo G, Dobos I, Klimscha W, Toth G, Benedek G. The synergistic antinociceptive interactions of endomorphin-1 with dexmedetomidine and/or S(+)-ketamine in rats. Anesth Analg 2001; 93:1018-1024.